PlainPatent
USPTO 2015–2025 USPTO PatentsView US Corporation

Dyne Therapeutics, Inc.

USPTO PatentsView assignee record — 50 granted patents across 5 technology areas, active 2021–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C07K (PEPTIDES).

Explore the portfolio See the ranking
50
Total patents granted
5
CPC technology areas
24.4
Avg claims per patent
—
5-year filing velocity

The verdict

Dyne holds 50 US patents across 5 technology areas — rank #6,643 of 50,000 tracked assignees.

#6,643
of 50,000 US assignees by volume
Top 6%
by Innovation Score (56.1/100)
24.4
avg claims per patent

Portfolio overview

Dyne Therapeutics, Inc. has been granted 50 US utility patents between 2021 and 2025, placing Dyne Therapeutics, Inc. at rank #6,643 across all assignees tracked by PlainPatent. This portfolio spans 5 distinct Cooperative Patent Classification (CPC) subclasses, averaging 24.4 claims per patent with primary concentration in C07K (PEPTIDES). As a US Corporation, Dyne Therapeutics, Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 56.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2021 through 2025, with 50 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Dyne Therapeutics, Inc.'s 24.4 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 5 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Dyne Therapeutics, Inc. against peers pursuing similar technology classes.

How does Dyne compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Dyne holds 50 patents — placing it at rank #6,643 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

Dyne's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

56 Top 6% higher than 94% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

05101520 20212022202320242025 13
USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table
Dyne Therapeutics, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2021 2 4.0%
2022 6 12.0%
2023 15 30.0%
2024 14 28.0%
2025 13 26.0%

Which technologies does Dyne Therapeutics, Inc. patent most?

Top 5 of 5 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Complex

Where it ranks

Overall rank by patents

#6,643

Across all tracked assignees

Innovation Score

56.1 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Dyne Therapeutics, Inc. hold?
Dyne Therapeutics, Inc. holds 50 US granted patents filed between 2021 and 2025, spanning 5 technology areas.
What is Dyne Therapeutics, Inc.'s Innovation Score?
Dyne Therapeutics, Inc. has an Innovation Score of 56.1 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Dyne Therapeutics, Inc. focus on?
Dyne Therapeutics, Inc.'s top technology area is C07K (PEPTIDES) with 49 patents. The company has filed patents in 5 CPC subclasses total.
Is Dyne Therapeutics, Inc.'s patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Dyne Therapeutics, Inc..
What does claim depth mean for Dyne Therapeutics, Inc.'s patents?
Dyne Therapeutics, Inc.'s patents average 24.4 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the Dyne Therapeutics, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How Innovation Score Works

Understand the four dimensions behind the composite score
How to Read Patent Data

Plain-English guide to CPC codes, claims, and metrics
Patent Moat Analysis

How companies use patents as competitive barriers

How to use this portfolio

Dyne's 50 grants land it in the top 6% by Innovation Score — but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance — Dyne ranks #6,643 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in C07K — see who else leads that technology area. C07K leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity — not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

C07K technology

Dyne Therapeutics, Inc.'s primary CPC class — all holders and yearly trends
Top 50 patent holders

See where Dyne Therapeutics, Inc. ranks among the largest US patent assignees
All technology classes

Browse every CPC technology area by patent activity
How the score works

The four dimensions behind the Innovation Score

Related

All companies → | All technologies → | Rankings →
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology — how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView — the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) — the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search — the official interface to verify the status of any individual patent. ppubs.uspto.gov